Overview of Acute Coronary Syndromes

nonâ€“ST-segment elevation MI; MI = myocardial infarction; PCI = percutaneous intervention; STEMI = ST-segment elevation MI. When the diagnosis is unclear, bedside cardiac biomarker measurements can help identify low-risk patients with a suspected ACS (eg, those with initially negative cardiac biomarkers and nondiagnostic ECGs), who can be managed in 24-hour observation units or chest pain centers. Higher-risk patients should be admitted to a monitored inpatient unit or critical care unit (CCU). Several validated tools can help stratify risk. Thrombolysis in MI (TIMI) risk scores may be the most widely used. Patients with suspected NSTEMI and intermediate or high risk should be admitted to an inpatient care unit or CCU. Those with STEMI should be admitted to a CCU. Only heart rate and rhythm recorded by single-lead ECG are consistently useful for routine, continuous monitoring. However, some clinicians recommend routine multilead monitoring with continuous ST- segment recording to identify transient, recurrent ST-segment elevations or depressions. Such findings, even in patients without symptoms, suggest ischemia and identify higher-risk patients who may require more aggressive evaluation and treatment. Qualified nurses can interpret the ECG for arrhythmia and initiate protocols for its treatment. All staff members should know how to do CPR (cardiopulmonary resuscitation).
